市場調査レポート

商品コード

1737148

点鼻スプレーの世界市場規模：治療用途別、流通経路別、エンドユーザー別、地域範囲別および予測

Global Nasal Spray Market Size By Use in Therapy, By Channel of Distribution, By End User, By Geographic Scope And Forecast

出版日: 2025年05月09日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日

価格

PDF (Single User License)

USD 3,950 569,116円

1名のみが、レポートにアクセスする事ができるライセンスです。レポートPDFのダウンロード、印刷は可能です。

PDF & Excel (5 User License)

USD 4,850 698,788円

5名までが、レポートにアクセスする事ができるライセンスです。レポートPDF・関連するExcelシートのダウンロード、印刷は可能です。

PDF & Excel (Enterprise User License)

USD 7,550 1,087,804円

人数制限なく、レポートにアクセスできるライセンスです。PDF形式のレポートと関連するExcel出力シートの両方をダウンロード、印刷する事が可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

点鼻スプレーの市場規模と予測

点鼻スプレー市場規模は、2024年に177億6,000万米ドルと評価され、2026年から2032年にかけてCAGR 5.69%で成長し、2032年には265億6,000万米ドルに達すると予測されます。

点鼻スプレーは、様々な症状を治療するために鼻から投与される液体の薬剤を製造、流通、販売することを指します。

点鼻スプレーには、鼻粘膜から素早く吸収されるように設計された、充血除去剤、抗ヒスタミン剤、ステロイド、生理食塩水など、さまざまな種類があります。

点鼻スプレーは、鼻腔を直接ターゲットにすることで迅速な緩和を提供するため、広く使用されています。

アレルギー、鼻づまり、副鼻腔炎、鼻炎などの呼吸器疾患の治療に効果的です。

ある種のスプレーは、ワクチン、ホルモン、または消化器系をバイパスして血流に速やかに吸収される必要のあるその他の薬剤を送達するために使用されます。

点鼻スプレーはまた、その使いやすさと非侵襲的な適用により好まれています。

点鼻スプレーの製造には、さまざまな健康状態を治療するために鼻から投与する液体薬の販売が含まれます。

これらのスプレーには、充血除去剤、抗ヒスタミン剤、ステロイド、生理食塩水などさまざまな種類があり、鼻腔を直接ターゲットにすることで迅速な緩和を提供します。

点鼻スプレーは、アレルギー、副鼻腔炎、鼻づまり、鼻炎などの呼吸器系疾患の治療に効果的であるため、広く使用されています。

また、消化器系をバイパスして血流に素早く吸収されることが必要なワクチン、ホルモン、薬剤の送達システムとしての役割も果たします。

点鼻スプレーは、呼吸療法や救急治療のために病院などのヘルスケア環境で一般的に使用されています。

点鼻スプレーの世界市場力学

世界の点鼻スプレー市場を形成している主な市場力学は以下の通り：

主な市場促進要因

アレルギーと呼吸器疾患の有病率の上昇：世界アレルギー機関（World Allergy Organization）によると、アレルギー性鼻炎は世界人口の10～30％が罹患しています。アレルギー性鼻炎、副鼻腔炎、喘息の増加により、点鼻スプレーの需要が高まっています。

迅速な薬物吸収と利便性：点鼻スプレーは、より迅速な緩和を提供し、非侵襲的であるため、経口薬よりも採用を奨励しています。

技術の進歩：米国国立衛生研究所（NIH）の報告によると、経鼻ドラッグデリバリーは、薬物の迅速な吸収が期待でき、血液脳関門を迂回できることから注目を集めています。Journal of Controlled Release誌に掲載された研究によると、先進ドラッグデリバリーシステムの世界市場は、2021年から2026年にかけてCAGR 6.5％で成長する見込みです。定量投与スプレーや複数回投与スプレーなどの技術革新が効率と精度を高め、市場の成長を後押ししています。

非処方薬の需要増加：市販の点鼻スプレーの利用可能性が高まることで、入手しやすくなり、市場の拡大が促進されます。

用途の拡大：点鼻スプレーは現在、ワクチン送達、ホルモン療法、疼痛管理などに使用され、市場範囲を広げています。

主な課題

副作用と過剰使用のリスク：点鼻スプレーの過剰使用や不適切な使用は、依存性や鼻乾燥などの副作用を引き起こす可能性があります。

高い製品開発コスト：医薬品グレードの点鼻スプレーの製造と規制当局の承認には多額の投資が必要となります。

代替治療との競合：錠剤、吸入器、その他の治療方法が代替品となり、市場の成長に影響を与えます。

厳しい規制要件：厳しいヘルスケア規制への対応により、製品の上市や技術革新が遅れる可能性があります。

保管と賞味期限の問題：一部の点鼻スプレーは保存期間が限られており、有効性を維持するためには適切な保管と管理が必要です。

主要動向

経鼻ワクチンの使用増加：インフルエンザワクチンやCOVID-19ワクチンの経鼻投与が検討されており、この分野の技術革新を促進しています。

天然・ハーブスプレーの成長：化学物質を含まない代替品を求めて、生理食塩水やハーブスプレーを選ぶ消費者が増えています。

スマートデバイスの採用：追跡機能と統合されたデジタル点鼻スプレーは投与量のモニターに役立ち、ヘルスケアのデジタル化の動向と一致しています。

セルフケアおよび家庭用製品へのシフト：セルフケア製品への需要の高まりにより、企業は使いやすい家庭用点鼻スプレーに注力します。

新興市場における地域需要の成長：アジア太平洋やラテンアメリカでは、都市化やライフスタイルの変化により需要が増加しています。

Technological Advancements: The U.S. National Institutes of Health (NIH) reports that nasal drug delivery is gaining attention due to its potential for rapid drug absorption and ability to bypass the blood-brain barrier. A study published in the Journal of Controlled Release found that the global market for advanced drug delivery systems is expected to grow at a CAGR of 6.5% from 2021 to 2026. Innovations such as metered-dose and multi-dose sprays enhance efficiency and precision, boosting market growth.

Increasing Demand for Non-prescription Medications: Growing availability of over-the-counter nasal sprays promotes accessibility and market expansion.

Expanding Applications: Nasal sprays are now used for vaccine delivery, hormone therapies, and pain management, widening the market scope.

Key Challenges

Side Effects and Overuse Risks: Excessive or improper use of nasal sprays can lead to dependency or side effects like nasal dryness.

High Product Development Costs: Manufacturing and regulatory approvals for pharmaceutical-grade nasal sprays require significant investment.

Competition from Alternative Treatments: Tablets, inhalers, and other treatment methods offer substitutes, affecting market growth.

Stringent Regulatory Requirements: Compliance with strict healthcare regulations can slow product launches and innovation.

Storage and Shelf-life Issues: Some nasal sprays have limited shelf lives, requiring proper storage and management to maintain effectiveness.

Key Trends

Rising Use of Nasal Vaccines: Nasal delivery is being explored for flu and COVID-19 vaccines, driving innovation in the sector.

Growth of Natural and Herbal Sprays: Consumers are increasingly opting for saline and herbal sprays, seeking chemical-free alternatives.

Adoption of Smart Devices: Digital nasal sprays integrated with tracking features help monitor doses, aligning with the trend of healthcare digitalization.

Shift Towards Self-care and Home Use Products: Rising demand for self-care products encourages companies to focus on easy-to-use nasal sprays for home use.

Regional Demand Growth in Emerging Markets: Countries in Asia-Pacific and Latin America are experiencing increased demand due to urbanization and changing lifestyles.

Global Nasal Spray Market Regional Analysis

Here is a more detailed regional analysis of the global nasal spray market:

North America

North America holds a significant share of the Global Nasal Spray Market, driven by the high prevalence of respiratory conditions such as allergic rhinitis, sinusitis, and asthma.

In the United States, the Centers for Disease Control and Prevention (CDC) reports that 19.2 million adults (7.7% of the population) were diagnosed with hay fever in 2018.

According to the U.S. Food and Drug Administration (FDA), there are over 300,000 approved OTC drug products on the market, including various nasal sprays.

The region's aging population, with increasing vulnerability to respiratory diseases, further fuels demand for both prescription and over-the-counter nasal sprays.

The widespread awareness about self-care and preventive healthcare practices has led to higher adoption of nasal sprays for allergies and cold relief.

Technological advancements, such as metered-dose and multi-dose sprays, along with innovations like digital tracking features in nasal devices, are propelling market growth.

The use of nasal sprays in innovative applications such as vaccine delivery and migraine management is expanding the scope of the market.

The region's robust pharmaceutical infrastructure and the presence of leading players, including Pfizer Inc. and GlaxoSmithKline, contribute to rapid product development and market expansion.

Regulatory approval processes by agencies like the U.S. FDA can pose challenges, but they also ensure the availability of high-quality products.

The growing demand for natural and saline-based sprays reflects shifting consumer preferences toward chemical-free solutions.

The increasing focus on home-use healthcare products aligns with the trend of self-administration, supporting the continuous growth of the nasal spray market in North America.

Asia Pacific

The Asia Pacific region is anticipated to experience significant growth in the Global Nasal Spray Market driven by rising awareness of respiratory health and increasing incidences of allergies, sinus infections, and viral respiratory conditions.

Rapid urbanization and industrialization have led to higher levels of pollution, contributing to respiratory issues among the population, which in turn has boosted demand for nasal sprays.

Countries such as China, India, and Japan are witnessing significant growth due to their large populations and increasing healthcare spending.

The adoption of over-the-counter (OTC) nasal sprays is growing, as consumers increasingly opt for quick-relief solutions for common colds, nasal congestion, and allergic rhinitis.

The rise in telemedicine services and e-commerce platforms is making nasal sprays more accessible to consumers in remote areas.

The market is also benefiting from an increased preference for natural and saline-based sprays, aligning with the growing trend toward herbal and non-chemical healthcare products.

Local manufacturers, along with global pharmaceutical companies, are expanding their presence in the region through collaborations and product launches.

The lack of stringent regulatory frameworks in some countries poses a challenge, affecting product quality.

The expanding middle-class population and heightened focus on preventive healthcare are expected to drive continuous market growth.

Global Nasal Spray Market: Segmentation Analysis

The Global Nasal Spray Market is segmented based on Use in Therapy, Channel of Distribution, End User, And Geography.

Nasal Spray Market, By Use in Therapy

Nasal sprays for Allergic Rhinitis
Nasal Congestion
Nasal Polyps
Infectious Rhinitis

Based on Use in Therapy, the Global Nasal Spray Market is classified into Nasal Sprays for Allergic Rhinitis, Nasal Congestion, Nasal Polyps, and Infectious Rhinitis. Nasal Sprays for Allergic Rhinitis dominate the Global Nasal Spray Market driven by the rising prevalence of allergic rhinitis, driven by increasing air pollution and allergens such as pollen, dust, and pet dander, is significantly fueling the demand for these sprays. Nasal sprays are highly effective in relieving symptoms such as sneezing, nasal itching, and runny nose, making them a popular choice for individuals suffering from seasonal allergies.

Nasal Spray Market, By Channel of Distribution

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores/Convenience Stores

Based on the Channel of Distribution, the Global Nasal Spray Market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores/Convenience Stores. Retail Pharmacies segment dominates the Global Nasal Spray Market. Retail pharmacies offer easy access to both over-the-counter (OTC) and prescription-based nasal sprays, catering to a wide range of customers. Their widespread presence in urban and rural areas, along with personalized services, makes them a preferred choice for consumers seeking quick solutions for nasal issues like congestion and allergies.

Nasal Spray Market, By End User

Adults
Paediatrics
Geriatrics

Based on the End User, the Global Nasal Spray Market is segmented into Adults, Paediatrics, and Geriatrics. The Adults segment dominates the Global Nasal Spray Market, driven by the high prevalence of conditions like allergic rhinitis, sinusitis, and nasal congestion in this population group. Busy lifestyles and increasing exposure to allergens and pollutants have led to a growing dependence on nasal sprays for quick relief.

Key Players

The "Global Nasal Spray Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Emergent Biosolutions Inc., Cipla Inc., Sandoz International GmbH (Novartis), Aytu Health (Aytu BioPharma), Bayer AG, GlaxoSmithKline plc., Assertio Therapeutics, Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd.

This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Nasal Spray Market Key Developments

In August 2023, Padagis LLC announced the launch of the first over-the-counter (OTC) Naloxone HCl Nasal Spray in the U.S., designed for rapid reversal of opioid overdose effects.
In May 2023 the U.S. FDA approved Opvee nasal spray, a user-friendly product that effectively counteracts overdoses caused by fentanyl and other opioids.
In 2019, Bayer Consumer Health announced a partnership with DKSH Cambodia, a leading provider of market expansion services for businesses seeking to grow in Asia.

1 INTRODUCTION OF GLOBAL NASAL SPRAY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
3.5 Market attractiveness

4 GLOBAL NASAL SPRAY MARKET, OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL NASAL SPRAY MARKET, BY THERAPY

5.1 Round-Trip Car Sharing
5.2 Nasal sprays for Allergic Rhinitis
5.3 Nasal Congestion
5.4 Nasal Polyps
5.5 Infectious Rhinitis

6 GLOBAL NASAL SPRAY MARKET, BY CHANNEL OF DISTRIBUTION

6.1 Fuel-based
6.2 Hospital Pharmacies
6.3 Retail Pharmacies
6.4 Online Pharmacies
6.5 Drug Stores/Convenience Stores

7 GLOBAL NASAL SPRAY MARKET, BY END USER

7.1 Fuel-based
7.2 Adults
7.3 Paediatrics
7.4 Geriatrics

8 GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL NASAL SPRAY MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
9.4 ACE Matrix

10 COMPANY PROFILES

10.1 Emergent Biosolutions Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Cipla Inc.
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Sandoz International GmbH (Novartis)
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Aytu Health (Aytu BioPharma)
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Bayer AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 GlaxoSmithKline plc
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Development
10.7 Assertio Therapeutics, Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Pfizer Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Development
10.9 Viatris Inc.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Development
10.10 Teva Pharmaceutical Industries Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Development

11 KEY DEVELOPMENTS

11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations

12 Appendix

12.1 Related Research

点鼻スプレーの世界市場規模：治療用途別、流通経路別、エンドユーザー別、地域範囲別および予測

Global Nasal Spray Market Size By Use in Therapy, By Channel of Distribution, By End User, By Geographic Scope And Forecast

点鼻スプレーの市場規模と予測

点鼻スプレーの世界市場力学

主な市場促進要因

目次

第1章 点鼻スプレー世界市場の導入

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

第4章 点鼻スプレーの世界市場、展望

第5章 点鼻スプレーの世界市場：治療法別

第6章 点鼻スプレーの世界市場：流通経路別

第7章 点鼻スプレーの世界市場：エンドユーザー別

第8章 点鼻スプレーの世界市場：地域別

第9章 点鼻スプレーの世界市場の競合情勢

第10章 企業プロファイル

第11章 主な発展

第12章 付録

Nasal Spray Market Size And Forecast

Global Nasal Spray Market Dynamics

Key Market Drivers

Global Nasal Spray Market Regional Analysis

Global Nasal Spray Market: Segmentation Analysis

Nasal Spray Market, By Use in Therapy

Nasal Spray Market, By Channel of Distribution

Nasal Spray Market, By End User

Key Players

Global Nasal Spray Market Key Developments

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NASAL SPRAY MARKET

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

4 GLOBAL NASAL SPRAY MARKET, OUTLOOK

5 GLOBAL NASAL SPRAY MARKET, BY THERAPY

6 GLOBAL NASAL SPRAY MARKET, BY CHANNEL OF DISTRIBUTION

7 GLOBAL NASAL SPRAY MARKET, BY END USER

8 GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY

9 GLOBAL NASAL SPRAY MARKET COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

11 KEY DEVELOPMENTS

12 Appendix

第1章点鼻スプレー世界市場の導入

第2章エグゼクティブサマリー

第4章点鼻スプレーの世界市場、展望

第5章点鼻スプレーの世界市場：治療法別

第6章点鼻スプレーの世界市場：流通経路別

第7章点鼻スプレーの世界市場：エンドユーザー別

第8章点鼻スプレーの世界市場：地域別

第9章点鼻スプレーの世界市場の競合情勢

第10章企業プロファイル

第11章主な発展

第12章付録